F2RL1 and chondrosarcoma: Future efforts will focus on translating OC’s PAR-2 modulation for chondrosarcoma and its PAR-2/TNF-α/calcium signaling effects for colorectal cancer, both involving detailed mechanistic studies and nanotherapeutic delivery.